Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Debt to Equity Ratio : 0.1763 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1763 |
| December 31, 2025 | 0.0255 |
| September 30, 2025 | 0.0371 |
| June 30, 2025 | 0.05 |
| March 31, 2025 | 0.0557 |
| December 31, 2024 | 0.0671 |
| September 30, 2024 | 0.0797 |
| June 30, 2024 | 0.0935 |
| March 31, 2024 | 0.1078 |
| December 31, 2023 | 0.1225 |
| September 30, 2023 | 0.133 |
| June 30, 2023 | 0.1417 |
| March 31, 2023 | 0.1547 |
| December 31, 2022 | 0.1674 |
| September 30, 2022 | 0.1465 |
| June 30, 2022 | 0.1106 |
| March 31, 2022 | 0.2782 |
| December 31, 2021 | 0.3283 |
| September 30, 2021 | 0.252 |
| June 30, 2021 | 0.4186 |
| March 31, 2021 | 0.8403 |
| December 31, 2020 | 1.113 |
| September 30, 2020 | 1.268 |
| June 30, 2020 | 1.835 |
| March 31, 2020 | 2.213 |
| Date | Value |
|---|---|
| December 31, 2019 | 3.538 |
| September 30, 2019 | 5.047 |
| June 30, 2019 | 6.812 |
| March 31, 2019 | 7.307 |
| December 31, 2018 | 22.12 |
| September 30, 2018 | 45.48 |
| June 30, 2018 | -2.781 |
| March 31, 2018 | -2.337 |
| December 31, 2017 | -2.294 |
| September 30, 2017 | -2.283 |
| June 30, 2017 | -2.574 |
| March 31, 2017 | -1.950 |
| December 31, 2016 | -1.925 |
| September 30, 2016 | -2.076 |
| June 30, 2016 | -1.880 |
| March 31, 2016 | -1.739 |
| December 31, 2015 | -1.716 |
| September 30, 2015 | -1.536 |
| June 30, 2015 | -1.529 |
| March 31, 2015 | -1.548 |
| December 31, 2014 | -1.692 |
| September 30, 2014 | -1.517 |
| June 30, 2014 | -1.457 |
| March 31, 2014 | -1.344 |
| December 31, 2013 | -1.504 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Medifast, Inc. | 0.1406 |
| BioForce Nanosciences Holdings, Inc. | 0.00 |
| Skinvisible, Inc. | -0.5436 |
| Nevis Brands, Inc. | 0.2521 |
| Skinhealth Systems, Inc. | 6.605 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.67M |
| Total Liabilities (Quarterly) | 7.687M |
| Shareholders Equity (Quarterly) | 18.98M |
| Current Ratio | 3.252 |
| Net Debt Paydown Yield | -4.81% |